Scarica l'app Stockscreener
48.30
4.79%
-2.43
Dopo l'orario di chiusura:
48.39
0.09
+0.19%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AA Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$50.73
Aprire:
$49.08
Volume 24 ore:
3.86M
Relative Volume:
0.71
Capitalizzazione di mercato:
$12.75B
Reddito:
$14.00B
Utile/perdita netta:
$1.26B
Rapporto P/E:
9.9079
EPS:
4.8749
Flusso di cassa netto:
$352.00M
1 W Prestazione:
-5.39%
1M Prestazione:
-6.45%
6M Prestazione:
-21.22%
1 anno Prestazione:
+56.16%
Intervallo 1D:
$48.18
$50.24
Intervallo di 1 settimana:
$48.18
$53.17
Portata 52W:
$30.71
$84.38
Agilent Technologies Inc Stock (AA) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
412-315-2900
Indirizzo
201 ISABELLA STREET, PITTSBURGH, PA
Compare AA vs TMO, DHR, NTRA, IQV, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AA
Agilent Technologies Inc
|
48.30 | 13.39B | 14.00B | 1.26B | 352.00M | 4.8749 |
TMO
Thermo Fisher Scientific Inc
|
603.18 | 223.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
200.53 | 144.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
326.14 | 47.61B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
257.30 | 42.30B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
143.12 | 40.81B | 7.23B | 1.41B | 1.09B | 4.979 |
Agilent Technologies Inc Stock (AA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-09 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2026-03-13 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2026-01-27 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2026-01-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2026-01-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-10-08 | Iniziato | Wells Fargo | Overweight |
| 2025-07-08 | Ripresa | Citigroup | Buy |
| 2025-05-15 | Downgrade | UBS | Buy → Neutral |
| 2025-04-08 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-10-23 | Aggiornamento | Argus | Hold → Buy |
| 2024-10-17 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2024-10-01 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-09-25 | Ripresa | JP Morgan | Neutral |
| 2024-09-04 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-08-12 | Aggiornamento | UBS | Sell → Buy |
| 2024-08-02 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2024-06-21 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-04-22 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-01-16 | Iniziato | UBS | Sell |
| 2023-12-07 | Iniziato | HSBC Securities | Hold |
| 2023-10-23 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-07-24 | Downgrade | Argus | Buy → Hold |
| 2023-07-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-07-11 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2023-06-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-05-11 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-05-08 | Iniziato | JP Morgan | Overweight |
| 2023-02-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-01-19 | Reiterato | B. Riley Securities | Neutral |
| 2022-12-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-07 | Iniziato | UBS | Neutral |
| 2022-09-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2022-09-16 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-21 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-08 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-11 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-11-17 | Iniziato | Wolfe Research | Outperform |
| 2021-11-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-10-05 | Reiterato | JP Morgan | Overweight |
| 2021-09-29 | Reiterato | Morgan Stanley | Overweight |
| 2021-09-15 | Aggiornamento | Argus | Hold → Buy |
| 2021-07-16 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-04-23 | Ripresa | JP Morgan | Overweight |
| 2021-03-24 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-03-17 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-03-03 | Aggiornamento | Goldman | Sell → Buy |
| 2020-09-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-06-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2020-03-24 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2020-03-04 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2020-01-17 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-12-17 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-13 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-11-12 | Reiterato | B. Riley FBR | Buy |
| 2019-11-07 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-10-21 | Downgrade | Gabelli & Co | Buy → Hold |
| 2019-09-26 | Reiterato | B. Riley FBR | Buy |
| 2019-09-23 | Downgrade | Goldman | Buy → Neutral |
| 2019-09-11 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-08-16 | Reiterato | BofA/Merrill | Neutral |
| 2019-07-19 | Downgrade | Argus | Buy → Hold |
| 2019-07-11 | Downgrade | Deutsche Bank | Buy → Hold |
| 2019-07-09 | Downgrade | Macquarie | Outperform → Neutral |
| 2019-04-22 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2019-04-03 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-04-02 | Downgrade | Credit Suisse | Outperform → Neutral |
Mostra tutto
Agilent Technologies Inc Borsa (AA) Ultime notizie
Agilent to Participate in J.P. Morgan U.S. All Stars Conference - Finviz
Agilent’s CEO and CFO will join a London fireside chat Sept. 23 - Stock Titan
Form 8K Agilent Technologies For: 10 September By Investing.com - Investing.com Canada
Agilent Technologies stock dips after insider buy and Q3 earnings strength - ad-hoc-news.de
Agilent files Form 3 initial beneficial ownership statement for director Glenn S. Boehnlein - Bitget
Insider Unloading: Mikael Dolsten Sells $95K Worth Of Agilent Technologies Shares - Benzinga
Major Purchase Alert: Glenn Boehnlein Invests $119K In Agilent Technologies Stock - Benzinga
Director at Agilent Technologies (A) gets 817-share stock grant - Stock Titan
Agilent (NYSE: A) director reports no direct stock - Stock Titan
Is Agilent Technologies Stock Outperforming the Dow? - Yahoo Finance
Agilent director Mikael Dolsten sells 634 shares for USD 95,980.75 - Bitget
Agilent Technologies Director Mikael Dolsten Reports Sale of 634 Shares - Kalkine Media
Agilent Technologies stock holds near 52-week high after guidance lift - ad-hoc-news.de
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Agilent Technologies (NYSE: A) director unloads 634 shares in early September trade - Stock Titan
Agilent Technologies Shares Fall After UBS Downgrade - marketscreener.com
UBS Downgrades Agilent Technologies to Neutral From Buy, $165 Price Target - Moomoo
Agilent Technologies (NYSE: A) Announces 2027 Board Leadership Changes with New Chair and Director - Kalkine Media
Agilent appoints new board chair and independent director - The Globe and Mail
Agilent Technologies Announces Board Chair Retirement and New Director Appointment - Kalkine Media
Agilent names Dow Wilson board chair after Koh Boon Hwee retires - Bitget
Agilent Names Dow Wilson Board Chair, Adds Former Stryker CFO Glenn Boehnlein - citybiz
Agilent Technologies Inc. Announces Board Changes, Effective September 4, 2026 - marketscreener.com
Agilent names new board chair, adds director By Investing.com - Investing.com Canada
Agilent names new board chair, adds director - Investing.com
Ex-Stryker finance chief joins Agilent (NYSE: A) board as chair role shifts - Stock Titan
Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors - Business Wire
Agilent Technologies stock gains on digital pathology launch and raised 2026 outlook - ad-hoc-news.de
Agilent (A) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Agilent Technologies, Inc. (A) Investor Outlook: Analyzing a 16.30% Potential Upside in the Diagnostics Sector - DirectorsTalk Interviews
Price to sales forward of Agilent Technologies, Inc. – MIL:1A - TradingView
Agilent Technologies stock gains as FDA-cleared S540MD slide scanner strengthens digital pathology p - ad-hoc-news.de
Agilent Technologies | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Mikael Dolsten to sell Agilent (NYSE: A) stock - Stock Titan
Worker says Agilent fired him to mask race and age bias - hcamag.com
Agilent Technologies stock gains on digital pathology launch and strong Q3 figures - AD HOC NEWS
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System - 01net
Agilent Technologies Launches FDA-Cleared S540MD Slide Scanner in US - marketscreener.com
Agilent launches FDA-cleared slide scanner in U.S. market - Investing.com
Agilent launches FDA-cleared slide scanner in U.S. market By Investing.com - Investing.com Australia
Agilent launches new ICP-MS, GC Systems and Digital Lab Execution platform in India - indianpharmapost.com
Baird Adjusts Price Target on Agilent Technologies to $180 From $169, Keeps Outperform Rating - marketscreener.com
Agilent Unveils Next‑Gen Lab Technologies to Boost India’s Testing Efficiency and Compliance - Indianweb2.com
Agilent Technologies Inc (A) Looks 2.6% Overvalued on GF Value™ - GuruFocus
Agilent: The Recovery Is Real, But So Is The Valuation (NYSE:A) - Seeking Alpha
A SWOT Analysis: Agilent Technologies Inc (A) Reveals Financial Insights in 10-Q Filing - GuruFocus
Bond swap: Agilent (NYSE: A) offers to exchange $600M in 4.9% notes - Stock Titan
Agilent (NYSE: A) readies global debt program with $100M default triggers - Stock Titan
Agilent Technologies 3Q 2026: Revenue $1.88B, EPS $1.28— 10-Q Summary - TradingView
Agilent (NYSE: A) spends $950M on Biocare — see how Q3 earnings and debt shifted - Stock Titan
Tranche Update on Agilent Technologies, Inc. (NYSE:A)'s Equity Buyback Plan announced on May 29, 2024. - marketscreener.com
Agilent Technologies Inc Azioni (AA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):